While it has somewhat lagged behind other industries, the biomanufacturing sector is increasingly adopting new technologies that support a more efficient future
New end-to-end compliant-ready workflow helps biotherapeutic protein manufacturers meet regulatory and attribute-based product analysis requirements for drug identity, purity, and quality
The DynaDrive portfolio offers features that support cell culture performance across scales and accommodate high-density and next-generation cell culture processes